A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)

Clinical trial NCT05067244 · COMPLETED

Trial details

NCT number: NCT05067244
Sponsor: Remedy
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Post Traumatic Stress Disorder

Start date: 2021-10-04
Primary completion: 2024-11-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.